Clifford Chance has advised Eurazeo Investment Manager on the financing granted to the international private equity fund Keensight Capital for the acquisition of Inke, S.A.U., a Spanish company leader in micronization of complex Active Pharmaceutical Ingredients (“APIs”) belonging to the Neuraxpharm pharmaceutical group.
The Clifford Chance financing team was led by Global Financial Markets Partner Rodrigo Uría and associate María Vispo.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
